Prothena Corporation plc Reports Updates to Its Leadership Team Prothena Corporation plc (NASDAQ: PRTA), a late-stage biotechnology company focused on developing therapies for diseases driven by protein dysregulation, has announced…
Covalon Technologies Ltd. Highlights Clinical Innovation and Infection Prevention Leadership at Infusion Nurses Society 2026 Annual Meeting Covalon Technologies Ltd., a company specializing in advanced medical technologies for wound care…
FairJourney Biologics Launches Cryo-EM Structural Biology Facility in San Diego FairJourney Bio (FJBio), a global contract research organization specializing in antibody discovery, has announced the opening of a cutting-edge cryo-electron…
Verastem Oncology Presents Two-Year Median Follow-Up Data for AVMAPKI®–FAKZYNJA® Combination in Recurrent Low-Grade Serous Ovarian Cancer at SGO 2026 Annual Meeting on Women’s Cancers Verastem Oncology (Nasdaq: VSTM), a company…
Bial Introduces Awareness and Education Initiative in Support of World Parkinson’s Day Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, has announced the launch of a major…
Ossium Health Welcomes Indiana Governor Mike Braun and Healthcare Leaders for Facility Tour and Reception Ossium Health recently opened its doors to state officials, healthcare leaders, and members of the…
New Billboards Highlight AHF as a Leading HIV Care Provider and Encourage STD Testing AIDS Healthcare Foundation (AHF), one of the largest nonprofit providers of HIV/AIDS care in the world,…
Vedanta Biosciences Highlights Advances in Microbiome-Based Therapeutics at ESCMID 2026 Global Congress Vedanta Biosciences, a late clinical-stage biopharmaceutical company focused on developing microbiome-based oral therapies for gastrointestinal diseases, has announced…
Charles River Promotes Cardiovascular Health Awareness with Support for the American Heart Association Charles River Laboratories International, Inc. (NYSE: CRL) has announced a new collaboration with the American Heart Association,…
Byondis Names Christoph Korpus, PhD, MBA as Chief Executive Officer, Strengthening Leadership with Multimedia Announcement Byondis B.V., an independent biotechnology company focused on the development of innovative targeted therapies for…
Emalex Awarded U.S. Patent for Its Orally Disintegrating Ecopipam Formulation Emalex Biosciences has announced a significant advancement in its drug development efforts with the issuance of a new patent by…
A Significant Proportion of Adults in the Community May Be Unaware They Are Living with Prediabetes The El Camino Healthcare District has launched a comprehensive new initiative aimed at tackling…